305 related articles for article (PubMed ID: 28871624)
1. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.
van Vugt JLA; Buettner S; Alferink LJM; Bossche N; de Bruin RWF; Darwish Murad S; Polak WG; Metselaar HJ; IJzermans JNM
Transpl Int; 2018 Feb; 31(2):165-174. PubMed ID: 28871624
[TBL] [Abstract][Full Text] [Related]
2. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
3. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
4. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
[TBL] [Abstract][Full Text] [Related]
5. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
Kuo SZ; Ahmad M; Dunn MA; Montano-Loza AJ; Carey EJ; Lin S; Moghe A; Chen HW; Ebadi M; Lai JC
Transplantation; 2019 Nov; 103(11):2312-2317. PubMed ID: 30985575
[TBL] [Abstract][Full Text] [Related]
7. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.
Sinclair M; Hoermann R; Peterson A; Testro A; Angus PW; Hey P; Chapman B; Gow PJ
Liver Int; 2019 Jun; 39(6):1089-1097. PubMed ID: 30746903
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
Durand F; Buyse S; Francoz C; Laouénan C; Bruno O; Belghiti J; Moreau R; Vilgrain V; Valla D
J Hepatol; 2014 Jun; 60(6):1151-7. PubMed ID: 24607622
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
Wang CW; Feng S; Covinsky KE; Hayssen H; Zhou LQ; Yeh BM; Lai JC
Transplantation; 2016 Aug; 100(8):1692-8. PubMed ID: 27314169
[TBL] [Abstract][Full Text] [Related]
10. A multicenter study to define sarcopenia in patients with end-stage liver disease.
Carey EJ; Lai JC; Wang CW; Dasarathy S; Lobach I; Montano-Loza AJ; Dunn MA;
Liver Transpl; 2017 May; 23(5):625-633. PubMed ID: 28240805
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation arrests and reverses muscle wasting.
Bergerson JT; Lee JG; Furlan A; Sourianarayanane A; Fetzer DT; Tevar AD; Landsittel DP; DiMartini AF; Dunn MA
Clin Transplant; 2015 Mar; 29(3):216-21. PubMed ID: 25557648
[TBL] [Abstract][Full Text] [Related]
12. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?
Stirnimann G; Ebadi M; Tandon P; Montano-Loza AJ
Curr Gastroenterol Rep; 2018 Sep; 20(11):50. PubMed ID: 30259203
[TBL] [Abstract][Full Text] [Related]
13. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease.
Kappus MR; Wegermann K; Bozdogan E; Patel YA; Janas G; Shropshire E; Parish A; Niedzwiecki D; Muir AJ; Bashir M
Liver Transpl; 2020 Sep; 26(9):1090-1099. PubMed ID: 32433802
[TBL] [Abstract][Full Text] [Related]
14. Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death.
Engelmann C; Schob S; Nonnenmacher I; Werlich L; Aehling N; Ullrich S; Kaiser T; Krohn S; Herber A; Sucher R; Bartels M; Surov A; Hasenclever D; Kahn T; Seehofer D; Moche M; Berg T
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1271-1281. PubMed ID: 30417398
[TBL] [Abstract][Full Text] [Related]
15. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
16. Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes.
Idriss R; Hasse J; Wu T; Khan F; Saracino G; McKenna G; Testa G; Trotter J; Klintmalm G; Asrani SK
Liver Transpl; 2019 Feb; 25(2):217-227. PubMed ID: 30369002
[TBL] [Abstract][Full Text] [Related]
17. Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia.
Alexopoulos T; Vasilieva L; Kontogianni MD; Tenta R; Georgiou A; Stroumpouli E; Mani I; Alexopoulou A
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G543-G551. PubMed ID: 34469188
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and liver transplant: The relevance of too little muscle mass.
Kallwitz ER
World J Gastroenterol; 2015 Oct; 21(39):10982-93. PubMed ID: 26494955
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
